Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    An Enquiry

    Menu

    rotigotine transdermal patch

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,910Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Comparing the Cost of Rotigotine API from Different Regions
    Comparing the Cost of Rotigotine API from Different Regions

    30 May 2024

    // PRESS RELEASE

    https://www.qingmupharm.com/comparing-the-cost-of-rotigotine-api-from-different-regions

    PRESS RELEASE
    30 May 2024
    Share Share
    Mitigating Shortages Strategies for Rotigotine Stable Supply
    Mitigating Shortages Strategies for Rotigotine Stable Supply

    08 May 2024

    // PRESS RELEASE

    https://www.qingmupharm.com/mitigating-shortages-strategies-for-a-stable-supply-chain-of-rotigotine-api

    PRESS RELEASE
    08 May 2024
    Share Share
    Understanding the Chemical Properties of Rotigotine API
    Understanding the Chemical Properties of Rotigotine API

    03 Apr 2024

    // PRESS RELEASE

    https://www.qingmupharm.com/understanding-the-chemical-properties-of-rotigotine-api

    PRESS RELEASE
    03 Apr 2024
    Share Share
    The Uses of Rotigotine in Parkinson’s Disease Treatment
    The Uses of Rotigotine in Parkinson’s Disease Treatment

    24 Jan 2024

    // PRESS RELEASE

    https://www.qingmupharm.com/the-uses-of-rotigotine-in-parkinsons-disease-treatment

    PRESS RELEASE
    24 Jan 2024
    Share Share
    UCB's second shot at Neupro patent validation fails on appeal
    UCB's second shot at Neupro patent validation fails on appeal

    13 Apr 2023

    // Nick Paul Taylor FIERCE PHARMA

    https://www.fiercepharma.com/pharma/appeals-court-shoots-down-ucbs-neupro-patch-patent-allowing-actavis-and-mylan-generics

    Nick Paul Taylor FIERCE PHARMA
    13 Apr 2023
    Share Share
    XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson
    XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson

    18 Oct 2022

    // ACCESSWIRE

    https://www.accesswire.com/720788/XPhyto-Reports-Excellent-Rotigotine-In-VitroEx-Vivo-Results-for-Parkinsons-Disease-Treatment

    ACCESSWIRE
    18 Oct 2022
    Share Share